Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00789685Phase 1/2Completed
Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II
Acute Lung InjuryAcute Respiratory Distress Syndrome
Principalinvestigator

Research Network

Collaboration Network

8 collaborators·28 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

St Mary's Hospital, London

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lorenzo Berra, MD

Massachusetts General Hospital

Moderately Similar
16 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteAcute Lung Injury
Similarity Score30%

davide chiumello, md

Policlinico Hospital

Moderately Similar
17 trials

Shared therapeutic areas:

Acute Lung InjuryRespiratory Distress Syndrome, Acute
Similarity Score30%

Alan Davidson, MD

Victoria Infirmary

Related
1 trials

Shared therapeutic areas:

Acute Lung InjuryRespiratory Distress Syndrome, Acute

Worked with same sponsors:

Faron Pharmaceuticals Ltd
Collaborated on 1 trial
Similarity Score24%

Richard Beale, MD

St Thomas' Hospital

Related
1 trials

Shared therapeutic areas:

Acute Lung InjuryRespiratory Distress Syndrome, Acute

Worked with same sponsors:

Faron Pharmaceuticals Ltd
Collaborated on 1 trial
Similarity Score24%

Timothy Walsh, MD

Edinburgh Royal Infirmary

Related
1 trials

Shared therapeutic areas:

Acute Lung InjuryRespiratory Distress Syndrome, Acute

Worked with same sponsors:

Faron Pharmaceuticals Ltd
Collaborated on 1 trial
Similarity Score24%

Martin Kuper, MD

Whittington Hospital

Related
1 trials

Shared therapeutic areas:

Acute Lung InjuryRespiratory Distress Syndrome, Acute

Worked with same sponsors:

Faron Pharmaceuticals Ltd
Collaborated on 1 trial
Similarity Score24%

Mathew Wise, MD

University Hospital of Wales

Related
1 trials

Shared therapeutic areas:

Acute Lung InjuryRespiratory Distress Syndrome, Acute

Worked with same sponsors:

Faron Pharmaceuticals Ltd
Collaborated on 1 trial
Similarity Score24%

Alexander Binning, MD

Western Infirmary

Related
1 trials

Shared therapeutic areas:

Acute Lung InjuryRespiratory Distress Syndrome, Acute

Worked with same sponsors:

Faron Pharmaceuticals Ltd
Collaborated on 1 trial
Similarity Score24%

Geoff Bellingan, MD

University College London Hospitals

Related
2 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteAcute Lung Injury

Worked with same sponsors:

Faron Pharmaceuticals Ltd
Collaborated on 1 trial
Similarity Score24%

Lionel Velly

APHM - La Timone

Related
1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Acute
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00789685Phase 1/2PrincipalInvestigator

Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II

Acute Lung InjuryAcute Respiratory Distress Syndrome
Completed

All 1 trials loaded